Markus Weiler
University of Freiburg(DE)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Neurogenetic and Muscular Disorders Research, Amyloidosis: Diagnosis, Treatment, Outcomes, RNA modifications and cancer, Congenital Anomalies and Fetal Surgery
Most-Cited Works
- → MGMT testing—the challenges for biomarker-based glioma treatment(2014)578 cited
- → SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma CellsIn vitroandIn vivo(2004)411 cited
- → Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study(2020)346 cited
- → RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates TumorigenicityIn vivo(2004)294 cited
- → Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation(2013)228 cited
- → mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy(2013)196 cited
- → Anterior interosseous nerve syndrome(2014)181 cited
- → Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy(2023)176 cited
- → Pathway inhibition: emerging molecular targets for treating glioblastoma(2011)144 cited
- → Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma(2012)144 cited